chartexchange

Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved SimpleScreen CRC Option

GlobeNewswire Inc. | Oct 20, 2026 8:30 AM EDT

Freenome Expands Personalized Cancer Detection Portfolio, Launching SimpleScreen™ Lung Test With FDA-Approved
SimpleScreen CRC Option

Read original article